Multicentre survey of retinopathy of prematurity in Indonesia

J Edy Siswanto1,2, Arend F Bos3, Peter H Dijk1

  • 1Neonatology, Universitair Medisch Centrum Groningen, Groningen, The Netherlands.

BMJ Paediatrics Open
|February 3, 2021
PubMed

Insights

Indonesia

Area of Science:

  • Ophthalmology
  • Neonatology
  • Public Health

Background:

  • Retinopathy of prematurity (ROP) incidence is higher in Indonesia compared to high-income nations.
  • A national ROP prevention and treatment protocol was implemented in 2010, with subsequent regional meetings to raise awareness.
  • National health insurance was introduced in 2014, improving access to ROP screening and treatment for infants.

Purpose of the Study:

  • To evaluate the impact of a national ROP guideline and health insurance on ROP incidence in Indonesia.
  • Assessing changes in ROP incidence following public health interventions.

Main Methods:

  • A survey was conducted in 34 Indonesian hospitals (national referral, university, public, private) from 2016-2017.
  • Data collected included infant admission numbers, mortality rates, and ROP incidence (all stages and severe) by gestational age and birth weight.
  • Analysis focused on comparing ROP incidence and outcomes in relation to interventions.

Main Results:

  • 12,115 preterm infants (<34 weeks GA) were analyzed; overall mortality was 24%, and any-stage ROP was 6.7%.
  • Infants <28 weeks GA had 67% mortality and 18% all-stage ROP incidence.
  • ROP incidence in 2016-2017 was lower than pre-2015 surveys, despite higher infant mortality compared to high-income countries.

Conclusions:

  • The ROP incidence in Indonesia is comparable to high-income countries, though likely underestimated due to high mortality.
  • The observed decline in ROP incidence is attributed to increased practitioner awareness and national health insurance.
  • Interventions have likely contributed to reducing ROP incidence, although challenges remain, particularly in university-based hospitals.
Abstract